Spotlight -

Drug Development|

Quality Systems

News|Articles|January 2, 2004

Pharmaceutical Technology

Pharmaceutical Technology-01-02-2004
Volume 28
Issue 1

Coprocessed Excipients for Solid Dosage Forms

Author(s)Arvind K. Bansal

The authors examine the development and performance of coprocessed excipients, including testing them for flowability, compressibility, amd dilution potential.

External Link - article-81434.pdf

Articles in this issue

over 22 years ago

Article

Manufacturing Execution Systems

over 22 years ago

Article

State-of-the-Art Packaging Machines

over 22 years ago

Article

over 22 years ago

Article

Medicare Bill Contains Significant Changes for Drug Manufacturers

over 22 years ago

Article

The Bioterrorism Act

over 22 years ago

Article

Establishing and Maintaining an Effective Gas Evaluation and Management Program

over 22 years ago

Article

New Supply-Chain Dynamics

over 22 years ago

Article

In the Spotlight--February 2004

over 22 years ago

Article

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Related Content

Genglycos (pariglasgene brecaparvovec-opnr), a gene therapy for adult and pediatric patients eight years and older with glycogen storage disease type Ia recieved accelerated approval from the FDA.

GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing

ByZachary Zubulake

August 20th 2026

Pasatru (garetosmab-grts) has been approved by the FDA to treat symptoms of fibrodysplasia ossificans progressiva

How a 63-Patient Trial Delivered an FDA Approval

ByZachary Zubulake

August 20th 2026

FDA concept | Concept of the Food and Drug Administration. Magnifier glass, folder and clock | Image Credit © Sviatlana - stock.adobe.com

What Does Overton's FDA Nomination Mean for Drug Reviews?

ByZachary Zubulake

August 19th 2026

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS) | © Tada Images - stock.adobe.com (521699065)

Ecopipam's D1 Receptor Approach Signals New Pediatric Neuroscience Pathway

ByZachary Zubulake

August 19th 2026

Adeno-associated viruses, 3D illustration | Image Credit: ©Dr_Microbe -stock.adobe.com

Andelyn Biosciences Partners with Queen's University on GM2 Gangliosidosis Gene Therapy

BySusan Haigney

August 18th 2026

Trending on Pharmaceutical Technology

What Does Overton's FDA Nomination Mean for Drug Reviews?

Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models

PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers

Ecopipam's D1 Receptor Approach Signals New Pediatric Neuroscience Pathway

Ask the Expert: Complying with Standards